European Society of Toxicology In Vitro > Affiliated Journals – TIV & ATLA > Special Issues > 2018 Special Issue: Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity
17 January 2020

2018 Special Issue: Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity

Reconstructed human epidermis (RhE) model for evaluation of medical devices irritant capacity

Edited by Wilhelmus de Jong, Bas J. Blaauboer, Kelly P. Coleman

  1. Evaluation of the medical devices benchmark materials in the controlled human patch testing and in the RhE in vitro skin irritation protocol Helena Kandárová, Hana Bendova, Silvia Letasiova, Kelly P. Coleman, … Dagmar Jírova. August 2018, Pages 433-438
  2. Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™ Helena Kandarova, Jamin A. Willoughby, Wim H. De Jong, Silvia Letasiova, … Kelly P. Coleman. August 2018, Pages 407-417
  3. Preparation of irritant polymer samples for an in vitro round robin study Kelly P. Coleman, Thomas P. Grailer, Lori R. McNamara, Beau L. Rollins, … Wim H. De Jong. August 2018, Pages 401-406.
  4. Reconstructed human epidermis models for irritant testing of medical devices Wim H. De Jong, Kelly P. Coleman, Bas J. Blaauboer. August 2018, Pages 399-400.
  5. SkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts Christian Pellevoisin, Christelle Videau, Damien Briotet, Corinne Grégoire, … Nathalie Seyler. August 2018, Pages 418-425.
  6. Round robin study to evaluate the reconstructed human epidermis (RhE) model as an in vitro skin irritation test for detection of irritant activity in medical device extracts Wim H. De Jong, Sebastian Hoffmann, Michelle Lee, Helena Kandárová, … Kelly P. Coleman. August 2018, Pages 439-449.
  7. Assessment of test method variables for in vitro skin irritation testing of medical device extracts Daniel S. Olsen, Michelle Lee, Audrey P. Turley. August 2018, Pages 426-432.

Related content

Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment

  • News

ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.

ESTIV 2026 LAST-MINUTE ABSTRACT SUBMISSION OPEN

We are pleased to announce that last‑minute poster abstract submissions are now open.

Researchers who still wish to contribute are warmly invited to submit their work. The deadline for last‑minute submissions is 8 May 2026 at 23:59 CET.

ESTIV-ASCCT:  Award Winners Series: AI & Machine Learning

Check out the details on the next installment of our ESTIV – ASCCT Award Winners Webinar and make sure to register if you haven’t already. We hope to see you there!

Silver Sponsor

Communication partners

Memorandum of Understanding